A Garber
Overview
Explore the profile of A Garber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garber A, Hastie P, Farci V, McGuinness D, Bulmer L, Alzahal O, et al.
Animal
. 2020 Jun;
14(12):2493-2502.
PMID: 32580805
There is a need to develop feeding strategies to prevent the adverse effect of concentrate feeding in high-performance horses fed energy-dense diets aiming to maintain their health and welfare. The...
2.
Garber A, Hastie P, Farci V, Bulmer L, Alzahal O, Murray J
Animal
. 2020 Jun;
14(12):2481-2492.
PMID: 32580794
Fibre is essential to maintain healthy gut; however, energy demands of performance horses can be too high to be met by forages alone. Yeast may support the function of cellulolytic...
3.
Garber A, Shenassa H, Singh S, Posner G
J Minim Invasive Gynecol
. 2016 Sep;
22(6S):S138.
PMID: 27678757
No abstract available.
4.
Plutzky J, Garber A, Falahati A, Toft A, Poulter N
Can J Diabetes
. 2015 May;
33(3):209-10.
PMID: 25998594
No abstract available.
5.
Pratley R, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S, et al.
Int J Clin Pract
. 2011 Mar;
65(4):397-407.
PMID: 21355967
Aim: The aim of this study was to compare the efficacy and safety of once-daily human glucagon-like peptide-1 analogue liraglutide with dipeptidyl peptidase-4 inhibitor sitagliptin, each added to metformin, over...
6.
Garber A, Henry R, Ratner R, Hale P, Chang C, Bode B
Diabetes Obes Metab
. 2011 Jan;
13(4):348-56.
PMID: 21205128
Aims: Most treatments for type 2 diabetes fail over time, necessitating combination therapy. We investigated the safety, tolerability and efficacy of liraglutide monotherapy compared with glimepiride monotherapy over 2 years....
7.
Bode B, Testa M, Magwire M, Hale P, Hammer M, Blonde L, et al.
Diabetes Obes Metab
. 2010 Jul;
12(7):604-12.
PMID: 20590735
Aim: As weight gain and hypoglycaemia associated with glimepiride therapy can negatively impact weight perceptions, psychological well-being and overall quality of life in type 2 diabetes, we investigated whether liraglutide...
8.
9.
Ray J, Valentine W, Roze S, Nicklasson L, Cobden D, Raskin P, et al.
Diabetes Obes Metab
. 2007 Jan;
9(1):103-13.
PMID: 17199725
Objectives: To project the long-term clinical and economic outcomes of treatment with biphasic insulin aspart 30 (BIAsp 70/30, 30% soluble and 70% protaminated insulin aspart) vs. insulin glargine in insulin-naïve...
10.
Rosenstock J, Rood J, Cobitz A, Biswas N, Chou H, Garber A
Diabetes Obes Metab
. 2006 Oct;
8(6):650-60.
PMID: 17026489
Aim: This study assessed the efficacy and safety of rosiglitazone and metformin (RSG/MET) fixed-dose combination (AVANDAMET) as initial therapy in patients with uncontrolled type 2 diabetes compared with monotherapy with...